Roles of Beta2- and Beta3-Adrenoceptor Polymorphisms in Hypertension and Metabolic Syndrome
Hypertension, diabetes mellitus (especially type 2 diabetes mellitus), metabolic syndrome and obesity are rapidly growing public health problems. Sympathetic nerve activation is observed in obesity, hypertension and diabetes mellitus, which have strong genetic as well as environmental determinants....
Saved in:
| Main Author: | Kazuko Masuo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.4061/2010/832821 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-3 Adrenoceptor Agonism Protects the Enteric Nervous Tissue Against Hyperoxia-Induced Damage
by: Patrizia Nardini, et al.
Published: (2025-03-01) -
Beta-adrenoceptor drugs and progression to Parkinson’s disease milestones in a large pooled incident cohort
by: Ruwani S. Wijeyekoon, et al.
Published: (2025-07-01) -
THE ROLE OF VASODILATING BETA-BLOCKERS IN PATIENTS WITH HYPERTENSION AND THE CARDIOMETABOLIC SYNDROME
by: A. A. Taylor, et al.
Published: (2011-08-01) -
Beta-adrenoblockers in patients with metabolic syndrome
by: V. B. Mychka, et al.
Published: (2008-04-01) -
Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers
by: V. N. Larina, et al.
Published: (2021-11-01)